ARCHIVES

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

This article is from The Cancer Letter archive.

Vol. 02 No. 45 | November 5, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

March 30, 2001

Maryland Contract Leafs New FY Awards

July 25, 1975

Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP

April 11, 1986

In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications

July 2, 1982

Ten Is The New 12: Medicare Lowers Hemoglobin Targets For ESA Use.

August 3, 2007

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000